Literature DB >> 10832071

Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults.

O T Raitakari1, R J McCredie, P Witting, K A Griffiths, J Letters, D Sullivan, R Stocker, D S Celermajer.   

Abstract

Oxidative modification of low-density lipoprotein (LDL) may cause arterial endothelial dysfunction in hyperlipidemic subjects. Antioxidants can protect LDL from oxidation and therefore improve endothelial function. Dietary supplementation with coenzyme Q (CoQ(10)) raises its level within LDL, which may subsequently become more resistant to oxidation. Therefore, the aim of this study was to assess whether oral supplementation of CoQ(10) (50 mg three times daily) is effective in reducing ex vivo LDL oxidizability and in improving vascular endothelial function. Twelve nonsmoking healthy adults with hypercholesterolemia (age 34+/-10 years, nine women and three men, total cholesterol 7.4+/-1.1 mmol/l) and endothelial dysfunction (below population mean) at baseline were randomized to receive CoQ(10) or matching placebo in a double-blind crossover study (active/placebo phase 4 weeks, washout 4 weeks). Flow-mediated (FMD, endothelium-dependent) and nitrate-mediated (NMD, smooth muscle-dependent) arterial dilatation were measured by high-resolution ultrasound. CoQ(10) treatment increased plasma CoQ(10) levels from 1.1 +/-0.5 to 5.0+/-2.8 micromol/l (p =.009) but had no significant effect on FMD (4.3+/-2.4 to 5.1+/-3.6 %, p =.99), NMD (21.6+/-6.1 to 20.7+/-7.8 %, p = .38) or serum LDL-cholesterol levels (p = .51). Four subjects were selected randomly for detailed analysis of LDL oxidizability using aqueous peroxyl radicals as the oxidant. In this subgroup, CoQ(10) supplementation significantly increased the time for CoQ(10)H(2) depletion upon oxidant exposure of LDL by 41+/-19 min (p = .04) and decreased the extent of lipid hydroperoxide accumulation after 2 hours by 50+/-37 micromol/l (p =.04). We conclude that dietary supplementation with CoQ(10) decreases ex-vivo LDL oxidizability but has no significant effect on arterial endothelial function in patients with moderate hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10832071     DOI: 10.1016/s0891-5849(00)00201-x

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  5 in total

Review 1.  Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease.

Authors:  Paul G Shekelle; Sally C Morton; Lara K Jungvig; Jay Udani; Myles Spar; Wenli Tu; Marika J Suttorp; Ian Coulter; Sydne J Newberry; Mary Hardy
Journal:  J Gen Intern Med       Date:  2004-04       Impact factor: 5.128

2.  Determination of ubidecarenone (coenzyme Q10, ubiquinol-10) in raw materials and dietary supplements by high-performance liquid chromatography with ultraviolet detection: single-laboratory validation.

Authors:  Debra Orozco; Jules Skamarack; Kelly Reins; Barry Titlow; Steve Lunetta; Fang Li; Mark Roman
Journal:  J AOAC Int       Date:  2007 Sep-Oct       Impact factor: 2.028

3.  Determination of coenzyme Q10 content in raw materials and dietary supplements by high-performance liquid chromatography-UV: collaborative study.

Authors:  Steven Lunetta; Mark Roman
Journal:  J AOAC Int       Date:  2008 Jul-Aug       Impact factor: 2.028

4.  Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.

Authors:  Jacopo Sabbatinelli; Patrick Orlando; Roberta Galeazzi; Sonia Silvestri; Ilenia Cirilli; Fabio Marcheggiani; Phiwayinkosi V Dludla; Angelica Giuliani; Anna Rita Bonfigli; Laura Mazzanti; Fabiola Olivieri; Roberto Antonicelli; Luca Tiano
Journal:  Nutrients       Date:  2020-04-15       Impact factor: 5.717

5.  Randomized clinical trial of the effect of intraoperative humidified carbon dioxide insufflation in open laparotomy for colorectal resection.

Authors:  J Y Cheong; B Chami; G M Fong; X S Wang; A Keshava; C J Young; P Witting
Journal:  BJS Open       Date:  2019-11-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.